Last Updated: July 06, 2024
mikle-pharm.com has 3 NS records, 1 A records, 0 AAAA records, 1 MX records, and 0 TXT records. Name servers for mikle-pharm.com are ns3.bw-networx.net, ns1.bw-networx.net, ns2.bw-networx.net. A records for mikle-pharm.com are 185.60.251.251. MX records that process @mikle-pharm.com email are mailgate.bw-networx.net. We have observed mikle-pharm.com to have 2 subdomains. A subdomain count of 2 is considered a small digital footprint. The domain's primary website is hosted on a nginx web server at 185.60.251.251 in Germany. The website's description is: "welcome to mikle-pharm we are your strategic partner for regulatory affairs and guide you through all stages of drug development and approval. drug development regulatory affairs life cycle" As of July 06, 2024, mikle-pharm.com does not have any threat intelligence reports of concern.
Search DigitalStakeout ASI to find another asset.
185.60.251.251
No DNS AAAA records
mailgate.bw-networx.net
ns3.bw-networx.net
ns1.bw-networx.net
ns2.bw-networx.net
No DNS TXT records
mikle-pharm.com has 2 subdomains in our inventory.
nginx
Germany
og:url: http://www.mikle-pharm.com/
og:title: home
og:description: welcome to mikle-pharm we are your strategic partner for regulatory affairs and guide you through all stages of drug development and approval. drug development regulatory affairs life cycle
og:type: website
og:locale: de_de
og:site_name: mikle-pharms webseite!
{"data":{"cert_index":892273789,"cert_link":"https:\/\/ct.googleapis.com\/logs\/eu1\/xenon2024\/ct\/v1\/get-entries?start=892273789&end=892273789","leaf_cert":{"all_domains":["mikle-pharm.com"],"extensions":{"authorityInfoAccess":"CA Issuers - URI:http:\/\/r3.i.lencr.org\/\nOCSP - URI:http:\/\/r3.o.lencr.org\n","authorityKeyIdentifier":"keyid:14:2E:B3:17:B7:58:56:CB:AE:50:09:40:E6:1F:AF:9D:8B:14:C2:C6\n","basicConstraints":"CA:FALSE","certificatePolicies":"Policy: 2.23.140.1.2.1","ctlSignedCertificateTimestamp":"BIHzAPEAdgCi4r_WHt4vLweg1k5tN6fcZUOwxrUuotq3iviabfUX2AAAAYz-jzgYAAAEAwBHMEUCIECt4mskzQai6Y3rvvbVB2ysb2hvA79UWtzOtzIzuB_BAiEAjURAWHi8_rPFVumTlHTNLlkhPtnDomS8fItJv0lyHaMAdwDuzdBk1dsazsVct520zROiModGfLzs3sNRSFlGcR-1mwAAAYz-jzgmAAAEAwBIMEYCIQDKUdFSwKOSevCT0BjjZoZUTP7OrGAsNvSJ8iYxA23v5AIhAPcJ-bfljPT9RtGvGQUCyxiANn4gYdR_qYpFq6bpR3Sr","extendedKeyUsage":"TLS Web server authentication, TLS Web client authentication","keyUsage":"Digital Signature, Key Encipherment","subjectAltName":"DNS:mikle-pharm.com","subjectKeyIdentifier":"99:FA:32:E1:42:2E:65:AB:A7:18:18:27:B9:08:83:ED:28:BF:A4:54"},"fingerprint":"0C:0E:F3:BC:0A:C9:C1:8E:38:06:2E:6E:4D:B5:4B:7C:7D:B6:15:2B","issuer":{"C":"US","CN":"R3","L":null,"O":"Let's Encrypt","OU":null,"ST":null,"aggregated":"\/C=US\/CN=R3\/O=Let's Encrypt","emailAddress":null},"not_after":1712850246,"not_before":1705074247,"serial_number":"41760118471E230AE9D8FB36E8D3D7D306E","signature_algorithm":"sha256, rsa","subject":{"C":null,"CN":"mikle-pharm.com","L":null,"O":null,"OU":null,"ST":null,"aggregated":"\/CN=mikle-pharm.com","emailAddress":null}},"seen":1705078279.299668,"source":{"name":"Google 'Xenon2024' log","url":"https:\/\/ct.googleapis.com\/logs\/eu1\/xenon2024\/"},"update_type":"X509LogEntry"},"message_type":"certificate_update"}